Literature DB >> 23348754

A brief history of oxytocin and its role in modulating psychostimulant effects.

Dean S Carson1, Adam J Guastella, Emily R Taylor, Iain S McGregor.   

Abstract

Over the past century, the polypeptide oxytocin has played an important role in medicine with major highlights including the identification of its involvement in parturition and the milk let-down reflex. Oxytocin is now implicated in an extensive range of psychological phenomena including reward and memory processes and has been investigated as a treatment for several psychiatric disorders including addiction, anxiety, autism, and schizophrenia. In this review, we first provide an historical overview of oxytocin and describe key aspects of its physiological activity. We then outline some pharmacological limitations in this field of research before highlighting the role of oxytocin in a wide range of behavioral and neuronal processes. Finally, we review evidence for a modulatory role of oxytocin with regard to psychostimulant effects. Key findings suggest that oxytocin attenuates a broad number of cocaine and methamphetamine induced behaviors and associated neuronal activity in rodents. Evidence also outlines a role for oxytocin in the prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) in both rodents and humans. Clinical trials should now investigate the effectiveness of oxytocin as a novel intervention for psychostimulant addiction and should aim to determine its specific role in the therapeutic properties of MDMA that are currently being investigated.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23348754     DOI: 10.1177/0269881112473788

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  27 in total

1.  Direct Involvement of Androgen Receptor in Oxytocin Gene Expression: Possible Relevance for Mood Disorders.

Authors:  Dan Dai; Qiao-Chu Li; Qiong-Bin Zhu; Shao-Hua Hu; Rawien Balesar; Dick Swaab; Ai-Min Bao
Journal:  Neuropsychopharmacology       Date:  2017-04-27       Impact factor: 7.853

2.  A two-week pilot study of intranasal oxytocin for cocaine-dependent individuals receiving methadone maintenance treatment for opioid use disorder.

Authors:  Christopher S Stauffer; Vivek Musinipally; Angela Suen; Kara L Lynch; Brad Shapiro; Joshua D Woolley
Journal:  Addict Res Theory       Date:  2016-05-25

3.  Plasma oxytocin concentrations are lower in depressed vs. healthy control women and are independent of cortisol.

Authors:  Kaeli W Yuen; Joseph P Garner; Dean S Carson; Jennifer Keller; Anna Lembke; Shellie A Hyde; Heather A Kenna; Lakshika Tennakoon; Alan F Schatzberg; Karen J Parker
Journal:  J Psychiatr Res       Date:  2013-12-28       Impact factor: 4.791

4.  Cerebrospinal fluid and plasma oxytocin concentrations are positively correlated and negatively predict anxiety in children.

Authors:  D S Carson; S W Berquist; T H Trujillo; J P Garner; S L Hannah; S A Hyde; R D Sumiyoshi; L P Jackson; J K Moss; M C Strehlow; S H Cheshier; S Partap; A Y Hardan; K J Parker
Journal:  Mol Psychiatry       Date:  2014-11-04       Impact factor: 15.992

5.  Complexity of oxytocin׳s effects in a chronic cocaine dependent population.

Authors:  Mary R Lee; Matthew Glassman; Brooks King-Casas; Deanna L Kelly; Elliot A Stein; Jennifer Schroeder; Betty Jo Salmeron
Journal:  Eur Neuropsychopharmacol       Date:  2014-07-01       Impact factor: 4.600

6.  Oxytocin Acts in Nucleus Accumbens to Attenuate Methamphetamine Seeking and Demand.

Authors:  Brittney M Cox; Brandon S Bentzley; Helaina Regen-Tuero; Ronald E See; Carmela M Reichel; Gary Aston-Jones
Journal:  Biol Psychiatry       Date:  2016-12-01       Impact factor: 13.382

7.  Nanoparticle formulations that allow for sustained delivery and brain targeting of the neuropeptide oxytocin.

Authors:  Rokon Uz Zaman; Nihal S Mulla; Keegan Braz Gomes; Cherilyn D'Souza; Kevin Sean Murnane; Martin J D'Souza
Journal:  Int J Pharm       Date:  2018-07-19       Impact factor: 5.875

8.  The effects of intranasal oxytocin in opioid-dependent individuals and healthy control subjects: a pilot study.

Authors:  Josh D Woolley; Peter A Arcuni; Christopher S Stauffer; Daniel Fulford; Dean S Carson; Steve Batki; Sophia Vinogradov
Journal:  Psychopharmacology (Berl)       Date:  2016-05-03       Impact factor: 4.530

Review 9.  Intranasal oxytocin effects on social cognition: a critique.

Authors:  Simon L Evans; Olga Dal Monte; Pamela Noble; Bruno B Averbeck
Journal:  Brain Res       Date:  2013-11-14       Impact factor: 3.252

10.  Effects of adverse childhood experiences on the association between intranasal oxytocin and social stress reactivity among individuals with cocaine dependence.

Authors:  Julianne C Flanagan; Nathaniel L Baker; Aimee L McRae-Clark; Kathleen T Brady; Margaret M Moran-Santa Maria
Journal:  Psychiatry Res       Date:  2015-07-23       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.